Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rare pulmonary neoplasms

D L Miller1, M S Allen

  • 1Division of Thoracic and Cardiovascular Surgery, Mayo Clinic Rochester, Minnesota.

Mayo Clinic Proceedings
|May 1, 1993
PubMed
Summary
This summary is machine-generated.

This study analyzed 80 rare pulmonary neoplasm cases, finding that cell type and disease stage significantly impact survival. Overall 5-year survival was 39% for these uncommon lung cancers.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early and long-term results of prosthetic chest wall reconstruction.

The Journal of thoracic and cardiovascular surgery·1999
Same author

Sonoporation of cultured cells in the rotating tube exposure system.

Ultrasound in medicine & biology·1999
Same author

Clinical progression of transplanted large granular lymphocytic leukemia in Fischer 344 rats exposed to 60 Hz magnetic fields.

Bioelectromagnetics·1999
Same author

Editing of cytochrome b mRNA in physarum mitochondria.

The Journal of biological chemistry·1999
Same author

Uncut Collis-Nissen fundoplication: learning curve and long-term results.

The Annals of thoracic surgery·1999
Same author

Results of reoperation on the upper esophageal sphincter.

The Journal of thoracic and cardiovascular surgery·1998
Same journal

37-Year-Old Woman With Jaundice.

Mayo Clinic proceedings·2026
Same journal

34-Year-Old Woman With An Unidentified Overdose.

Mayo Clinic proceedings·2026
Same journal

Use of Bronchoscopic Cryobiopsy in Evaluating Interstitial Lung Disease: Radiologic Predictors of Diagnostic Yield and Safety.

Mayo Clinic proceedings·2026
Same journal

Advancing Pulmonary Fibrosis Care: Integrating Genomic Insights Into Clinical Practice.

Mayo Clinic proceedings·2026
Same journal

RAAS Inhibition in the ICU: Stop, Continue, or Restart?

Mayo Clinic proceedings·2026
Same journal

Chronic Kidney Disease-In the Limelight, July 2026.

Mayo Clinic proceedings·2026
See all related articles

Area of Science:

  • Pulmonology
  • Oncology
  • Pathology

Background:

  • Rare pulmonary neoplasms represent a small fraction (0.8%) of primary lung cancer cases.
  • This study focuses on 80 patients treated at the Mayo Clinic between 1980 and 1990.

Purpose of the Study:

  • To review the clinical course and treatment outcomes for patients with rare pulmonary neoplasms.
  • To identify factors influencing survival in this patient cohort.

Main Methods:

  • Retrospective review of 80 patients diagnosed with rare pulmonary neoplasms.
  • Analysis of treatment modalities including pulmonary resection, chemotherapy, and radiation therapy.
  • Complete follow-up data collection with a median duration of 59 months.

Main Results:

Related Experiment Videos

  • Non-Hodgkin's lymphoma (41%) and carcinosarcoma (20%) were the most common rare types.
  • Pulmonary resection was performed in 79% of patients.
  • The overall 5-year survival rate was 39%.

Conclusions:

  • Histopathologic cell type and the extent of disease at initial diagnosis are critical determinants of survival.
  • Effective treatment strategies for rare pulmonary neoplasms require consideration of these prognostic factors.